COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and … between IP, innovation, access, and public health between stakeholders with divergent interests. This working paper provides …

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten …), have been approved by the World Health Organization (WHO) for inclusion in its Emergency Use Listing (EUL). The analysis is … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed …

This paper analyses the development of universities' patent applications in Germany before and after the abolition of … the 'professors' privilege' in 2002. By means of a database with all patent applications of German universities with … legislation is found only for universities without patent activities in the past. This indicates the importance of collecting …

the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any … governments should bear the cost of the expected increased industry obsolescence determined by a temporary patent waiver; this … includes public patent-buy-outs and regulated public-private R&D partnerships. …

infectious diseases disproportionately affecting the world’s poor as a foreign policy issue, mobilizing billions in global health …

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …